• Announces new €10 million R&D facility to house global device engineering 
  • Creates 40 R&D jobs and grows total to 120 new roles at new site 

Dublin, Monday, 19 September 2016 – Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today officially opened its new offices in College Business and Technology Park in Blanchardstown, Dublin, and announced creation of a new €10 million state-of-the-art Research and Development (R&D) facility at the location. The R&D facility will house global device engineering for the company and bring 40 more new jobs to the site, bringing the overall total of new positions there to 120 by 2017.